跳至主要内容
临床试验/ACTRN12623000870651
ACTRN12623000870651尚未招募3 期

ong-term effects of a cannabis-based medication on insomnia in chronic back pain: a randomized crossover trial

IVERSITY OF AUCKLAND0 个研究点目标入组 20 人开始时间: 2023年8月14日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
25 Years 至 85 Years(—)
性别
All

入选标准

  • Already a patient in the Bay of Plenty chronic pain services
  • Chronic back pain without evidence of radiculopathy or a serious underlying disease
  • Age:25-85
  • Pain score >4 on Numerical Rating Scale (NRS)at baseline visit
  • Insomnia Severity Index (ISI) score >14 at baseline visit
  • Treatment regimen for pain or insomnia stable for three months before baseline

排除标准

  • Current use of cannabis products
  • History of significant mental illness, alcohol, or drug abuse
  • Untreated cardiovascular or metabolic disorders, renal or hepatic impairment
  • Other significant sleep disorders
  • Use of medication which can interact with IMP
  • Use of new pain or insomnia treatments during the study

研究者

发起方
IVERSITY OF AUCKLAND

相似试验